Aberrant Expression of Pneumocytic Markers (TTF-1 and Napsin-A) in Biliary Duct and Gallbladder Adenocarcinomas;A Potential Diagnostic Pitfall

Abstract

Cholangiocarcinomas and gallbladder carcinomas are epithelial tumours with biliary differentiation. On histology and immunohistochemistry, they resemble adenocarcinomas and possess overlapping immunohistochemical profiles. Diagnosing these tumours is best done using appropriate imaging and clinical features with compatible immunohistochemistry. Immuno-staining for thyroid transcription factor-1 (TTF-1) and novel aspartic proteinase of pepsin A (Napsin-A) is believed to be specific for primary pulmonary adenocarcinomas. We herein report uncommon instances of strong and diffuse expression of these markers in two examples of adenocarcinomas arising from the bile duct and gallbladder. A review of the literature and a summary of similar studies relating to aberrant TTF-1 and Napsin-A expression in biliary tract adenocarcinomas are presented.

Keywords

cholangiocarcinoma gallbladder carcinoma TTF-1 napsin-A immunohistochemistry

Get full access to this article

View all access options for this article.

References

Lazaridis

Gores

. Cholangiocarcinoma. Gastroenterology. 2005;128(6):1655-1667.

Takahashi

Dungubat

Kusano

, et al. Application of immunohistochemistry in the pathological diagnosis of liver tumors. Int J Mol Sci. 2021;22(11):5780.

Jin

Liu

Wang

. Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma. Biotech Histochem Off Publ Biol Stain Comm. 2018;93(5):364-372.

Iqbal

. Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma. Arch Pathol Lab Med. 2013;137(2):155.

Pegolo

Machin

Damante

Di Loreto

TTF-1 Positivity in 2 cases of adenocarcinoma of the gastrointestinal tract. Appl Immunohistochem Mol Morphol. 2014;22(7):e27.

Lau

Luthringer

Eisen

. Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol AIMM. 2002;10(2):97-102.

Weidemann

Böhle

Contreras

, et al. Napsin A expression in human tumors and normal tissues. Pathol Oncol Res. 2021;27:613099.

Yatabe

Dacic

Borczuk

, et al. Best practices recommendations for diagnostic immunohistochemistry in lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2019;14(3):377-407.

Mukhopadhyay

Katzenstein

ALA

. Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas. Am J Clin Pathol. 2012;138(5):703-711.

10.

Kadivar

Boozari

. Applications and limitations of immunohistochemical expression of “Napsin-A” in distinguishing lung adenocarcinoma from adenocarcinomas of other organs. Appl Immunohistochem Mol Morphol. 2013;21(3):191.

11.

Surrey

Frank

Zhang

Furth

. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol. 2014;38(2):224-227.

12.

Lino-Silva

Salcedo-Hernández

García-Gómez

, et al. Thyroid transcription factor-1 expression in adenocarcinomas of the bile duct. Int J Surg Pathol. 2016;24(1):24-28.

13.

Nakamura

Miyagi

Murata

Kawaoi

Katoh

. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues. Mod Pathol Off J U S Can Acad Pathol Inc. 2002;15(10):1058-1067.

14.

Roy

Jain

Yadav

Mathur

Iyer

. TTF-1 and Napsin-A are not markers for biliary phenotype: an immunohistochemical study of gallbladder adenocarcinomas. Am J Surg Pathol. 2015;39(12):1742-1744.